Richard Gaster - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Richard Gaster’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Patient Care,
- Health Care,
- Drug Discovery,
- Autoimmune Diseases,
- Wellness,
- Women Founded,
- Life Science,
- Medical Technologies,
- Manufacturing,
- Biotechnology,
- Drug Development,
- Electronic Health Records (EHR),
- Health and Hospital Services,
- Clinical Trials,
- Vaccines,
- Digital Health,
- Medical,
- B2B,
- Therapeutics,
- Media and Entertainment,
- Pharmaceuticals,
- Risk Management
Social media:
Past investments:
- Attralus
- Aurinia Pharmaceuticals
- Labrys Biologics
- Adaptimmune
- Metacrine
- Seragon Pharmaceuticals
- NorthSea Therapeutics
- Solstice Biologics
- Myoventive
- Outlook Therapeutics
- Stargazer Pharmaceuticals
- Heart Metabolics
- Turning Point Therapeutics
- NorthSea Therapeutics B.V.
- Precision BioSciences
- Entact Bio
- Aeovian Pharmaceuticals
- Akero Therapeutics
- Harmony Biosciences
- RayzeBio
- Ventyx Biosciences
- Elevation Oncology
- ALX Oncology
- Alumis
- Impel NeuroPharma
- Swift Health Systems Inc.
- Checkmate Pharmaceuticals
- Yarrow
- Apellis Pharmaceuticals
- Tallac Therapeutics
- ACELYRIN, INC.
- Bellicum Pharmaceuticals
- 35Pharma
- Cytos
- Artiva Biotherapeutics
- Stem Cell Therapeutics
- VYNE Therapeutics
- Cidara Therapeutics
- Arrakis Therapeutics
- INBRACE
- Pharvaris
- Neurogastrx
- NFlection Therapeutics
- Aragon Pharmaceuticals
- Fog Pharmaceuticals
Investor Profile
Richard Gaster is a Venture Capital, Private Equity Firm, Investor based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune, Metacrine, Seragon Pharmaceuticals, NorthSea Therapeutics, Solstice Biologics, Myoventive, Outlook Therapeutics, Stargazer Pharmaceuticals, Heart Metabolics, Turning Point Therapeutics, NorthSea Therapeutics B.V., Precision BioSciences, Entact BioAeovian Pharmaceuticals, Akero Therapeutics, Harmony Biosciences, RayzeBio, Ventyx Biosciences, Elevation Oncology, ALX Oncology, Alumis, Impel NeuroPharma, Swift Health Systems Inc., Checkmate Pharmaceuticals, Yarrow, Apellis Pharmaceuticals, Tallac Therapeutics, ACELYRIN, INC., Bellicum Pharmaceuticals, 35Pharma, Cytos, Artiva Biotherapeutics, Stem Cell Therapeutics, VYNE Therapeutics, Cidara Therapeutics, Arrakis Therapeutics, INBRACE, Pharvaris, Neurogastrx, NFlection Therapeutics, Aragon Pharmaceuticals, Fog Pharmaceuticals, . Over time, Richard Gaster has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Richard Gaster is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Drug Discovery, Autoimmune Diseases, Wellness, Women Founded, Life Science, Medical Technologies, Manufacturing, Biotechnology, Drug Development, Electronic Health Records (EHR), Health and Hospital Services, Clinical Trials, Vaccines, Digital Health, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals, Risk Management may find it worthwhile to explore potential connections with Richard Gaster, as their portfolio suggests a familiarity and interest in this area.
Understanding Richard Gaster’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
